This federal contract award, valued at $11,862.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3010|SPE2DB25FP1GU) for the provision of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of January 2, 2025.
The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The DLA, a defense agency, is the funding agency for this contract.
Generated 4/1/25, 10:55 AM